Pharmaceuticals & Biotech
A technology suite that creates, maintains, and augments unique datasets for companies spanning all phases of the research pipeline to inform decision making and landscaping.
How We Help
We know that the success of innovation sourcing, drug discovery, pre-clinical trials, and clinical trials hinges on data-driven insights at the macro and micro resolutions. Shore provides for pharmaceutical and biotech companies, as well as service providers in those sectors solutions to make smarter decisions about potential collaboration partners and areas for investment.
- Key Opinion Leaders (KOLs)
- Strategy Groups
- Medical Communications
- Academic Partnering
Shore has worked as a data management provider with pharmaceutical companies and various organizations along the drug development pipeline, such as CROs, Clinical Research Labs, medical communication companies, and competitive intelligence companies. Our solutions enable these companies to focus on the science while Shore ensures data infrastructure is built to scale and produces actionable insights.
Custom data collection initiative
We specialize in partnering with companies who need a dataset collected that can used in their products or used for internal research. Examples range from collecting hospital data, Key Opinion Leaders (KOLs), ACOs, and physicians. Below are a few common use-cases, but our custom data division is able to collect any dataset in the pharmaceutical market.
Disambiguation of researcher metadata
Shore works hard to take stock of researchers at your institution to link publications, patents/IP, grants, awards, and clinical trial records to the correct faculty researchers, opening up countless opportunities for data-driven insights and newfound, powerful connections.
Lead generation for collaboration and RFP’s
Leverage metadata to scope out ideal audiences for specialized projects and teams across a range of institutions and disciplines.
Opportunity and IP sourcing
Effectively identify opportunities for partnerships and collaboration, as well as ready-made research IP for acquisition or further-development.